Home Giaconda

Giaconda

In operation
-
Gastrointestinal Disease Treatment Developer
Basic
Enterprise Profile

Basic Information

Giaconda Limited is dedicated to the development and commercialization of treatments for gastrointestinal diseases. The company's pipeline includes Hepaconda, for the treatment of hepatitis C virus, and Ibaconda.
Giaconda Limited
Sydney,NewSouthWales,Australia
less than 15 people
January 01, 2004
info@giacondalimited.com

Enterprise Profile

Industrial Sector
New Drug Development
Technology
Biotechnology
Concept
Infectious Diseases Gastric Cancer Irritable Bowel Syndrome
Application Scenarios
Innovative Drugs